CareDx, Inc. (CDNA)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 379,805,000 13.8%
- Net income
- -21,354,000 -140.6%
- Operating income
- -30,781,000
- Earnings per share
- -0.40 -140%
- R&D expense
- 71,429,000
Growth and profitability
- Operating margin
- -8.10
- Net margin
- -5.62
- Return on equity
- -7.05
- Return on assets
- -5.17
Balance sheet
- Total assets
- 413,228,000
- Total liabilities
- 110,127,000
- Shareholders' equity
- 303,101,000
- Cash and equivalents
- 65,429,000
- Current ratio
- 2.86
Cash flow and ratios
- Operating cash flow
- 42,032,000
Shareholder returns
- Share buybacks
- 87,768,000
- Shares outstanding
- 52,542,786
- Book value per share
- 5.77
Company information
- Headquarters
- Brisbane, CA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Services-Medical Laboratories
Fiscal year end: · Source: SEC EDGAR
CareDx, Inc. trades on NASDAQ under the ticker symbol CDNA. This page brings together its price chart, company profile, key financial figures and technical indicators.